Patents by Inventor Niklas Arnberg

Niklas Arnberg has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • ADENOVIRUS VECTORS AND USES THEREOF
    Publication number: 20220372515
    Abstract: Provided herein are chimeric adenoviral vectors. The provided chimeric adenoviral vectors can be used to induce a protective immune response and/or express a transgene in a subject in need thereof.
    Type: Application
    Filed: October 2, 2020
    Publication date: November 24, 2022
    Inventors: Jerome Hubertina Henricus Victor CUSTERS, Menzo Jans Emko HAVENGA, Monika BALLMANN, Angelique Alida Corina LEMCKERT, Andrew BAKER, Niklas ARNBERG, Gyozo KAJAN
  • Multivalent sialic acid derivatives
    Patent number: 10011628
    Abstract: Disclosed is tri- or tetravalent sialic acid derivatives comprising a core moiety to which 3 or 4 sialic acid residues are connected via a linker. Such derivatives inhibit the binding of adenovirus to human cells, whereby infections, such as epidemic keratoconjunctivitis, may be treated or prevented by administration of the tri- or tetravalent sialic acid derivatives.
    Type: Grant
    Filed: August 28, 2014
    Date of Patent: July 3, 2018
    Assignee: ADENOVIR PHARMA AB
    Inventors: Niklas Arnberg, Rémi Caraballo, Mikael Elofsson
  • MULTIVALENT SIALIC ACID DERIVATIVES
    Publication number: 20160207955
    Abstract: Disclosed is tri- or tetravalent sialic acid derivatives comprising a core moiety to which 3 or 4 sialic acid residues are connected via a linker. Such derivatives inhibit the binding of adenovirus to human cells, whereby infections, such as epidemic keratoconjunctivitis, may be treated or prevented by administration of the tri- or tetravalent sialic acid derivatives.
    Type: Application
    Filed: August 28, 2014
    Publication date: July 21, 2016
    Applicant: Adenovir Pharma AB
    Inventors: Niklas Arnberg, Rémi Caraballo, Mikael Elofsson
  • Method and composition for the treatment of adenoviral ocular infections
    Patent number: 7528113
    Abstract: Adenoviral infections and in particular ocular adenoviral infections, e.g. keratoconjunctivitis, can be treated or alleviated by the administration of a substance, interfering with the interaction between the virus and the sialic acid receptor, in a therapeutically effective amount.
    Type: Grant
    Filed: November 29, 2004
    Date of Patent: May 5, 2009
    Assignee: Adenovir Pharma AB
    Inventors: Goran Wadell, Niklas Arnberg
  • Method and composition for the treatment of adenoviral ocular infections
    Publication number: 20050080041
    Abstract: Adenoviral infections and in particular ocular adenoviral infections, e.g. kerato-conjunctivitis, can be treated or alleviated by the administration of a substance, interfering with the interaction between the virus and the sialic acid receptor, in a therapeutically effective amount.
    Type: Application
    Filed: November 29, 2004
    Publication date: April 14, 2005
    Inventors: Goran Wadell, Niklas Arnberg